Global Cow Milk Protein Allergy (CMPA) Market to flourish amid increasing prevalence of food allergy, Anticipates 7.6% CAGR Growth Through 2035
Nextgen Intelligence Stats outlines the projected growth across the global cow milk protein allergy market during 2025-2035 in a report. The global cow milk protein allergy market, valued at nearly US$ 799.44 million in 2024, exhibits the potential to reach US$ 1863.36 million by 2035, registering a CAGR of 7.6% over the forecasted timeframe.
The report Global Cow Milk Protein Allergy (CMPA) Market Size, Share, Trends, Industry Analysis Report is segmented by: By Product Type (Extensively Hydrolyzed Formulas (eHFs), Amino Acid-Based Formulas (AAFs), Soy-Based Formulas, Rice-Based Formulas, and Other Hypoallergenic Products), By End Users (Infants (0–12 months), Toddlers (1–3 years), and Children (Above 3 years)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Supermarkets/Hypermarkets) and Region, Market Forecast, 2025-2034 gives a detailed insight into current market dynamics and provides analysis on future market growth.
The cow milk protein allergy (CMPA) market is stimulated by an increasing prevalence of food allergy, especially in infants and young children. CMPA is among the most prevalent food allergy conditions in infants, frequently diagnosed during the first year of life. Growing awareness from parents and medical professionals about early detection and treatment of allergy is driving increased demand for proprietary products. The increased use of sophisticated diagnostic equipment and the greater knowledge of immune-related diseases further accelerated this demand. Increased consumption of infant formula and hypoallergenic foods, particularly in urban regions where breastfeeding levels can be lower, is one of the significant drivers. The clean-label movement, plant-based, and non-dairy trends also create new avenues for the market.
Potential exists in the creation of novel formulas, such as highly hydrolyzed and amino acid-based products that can be used by infants with extremely severe allergies. The continued research into probiotics and immune-modulating ingredients also presents promising routes for minimizing allergic reactions. With rising regulatory endorsement for allergy-friendly labeling and increasing consumer pressure for safe, clinically backed alternatives, the CMPA market is poised for long-term growth. Emerging markets, where awareness remains in the process of development, also offer unrealized opportunities for manufacturers and healthcare providers.
Discover Market Trends – Request a Complimentary Sample: https://nextgenintelligencestats.com/cow-milk-protein-allergy-market
- Extensively Hydrolyzed Formulas (eHFs) is the -leading segment valued for US$ 346.1 million in 2024. This is primarily a result of their proven efficacy and high rate of pediatrician recommendation among infants diagnosed or suspected of CMPA, most particularly those with mild to moderate presentations.
- Amino Acid-Based Formulas (AAFs) are the most rapidly expanding growing at a CAGR of 8.3%. This speedy growth is initiated by them being the least allergenic option and, hence, being critical for infants with severe CMPA, intricate food allergies, or those unresponsive to eHFs.
- Infants (0-12 months) have the largest market share. This is due to the presence of CMPA being most commonly diagnosed in the first year of life when the infant's immune system and digestive system are still developing.
- Hospital pharmacies is the biggest market segment. This is because the primary diagnosis of allergy is usually conducted at a hospital, where specific formulas are easily prescribed & dispensed.
- Online Pharmacies are the fastest-growing segment in the market. This is driven by increasing internet penetration, the ease of home delivery, and the rising availability of specialist products that may not be carried in local retail outlets regularly.
Regional Frontrunner
North America holds a significant proportion of the Cow Milk Protein Allergy (CMPA) market, led by the greater incidence of food allergies, superior healthcare infrastructure, and high awareness among consumers and physicians. It has the advantage of well-established diagnostic facilities and a developed market for niche nutritional solutions. The United States and Canada are among the top contributors, facilitated by high levels of healthcare spending and the presence of leading industry players. The Asia-Pacific will be the fastest-growing market in the forecast period. This is due to the propelling birth rates, increasing disposable incomes, improved access to healthcare services, and increased food allergy awareness in China, India, and Japan. In addition, the huge population base & faster uptake of Western dietary habits have also aided the rising number of food allergies.
The key players profiled in the Cow Milk Protein Allergy market report include Nestlé Health Science, Nutricia (a Danone Group company), Mead Johnson & Company, LLC, Abbott, Pharmalys, Novalac, Sanulac Nutritionals Australia Pty Ltd, Pristine Organics Pvt Ltd, ViPlus Dairy, and Hero Group.
Dive Into Our In-Depth Market Analysis: https://nextgenintelligencestats.com/request-sample-report/43